BTMD · biote Corp. · Documents

Aug 1

Registration statement S-1

Registration statement

Jul 28

Current report 8-K Events of Jul 27

Entered into a material agreement, Unregistered sale of equity

Jul 19

Current report 8-K Events of Jul 18

Delisting notice or listing transfer

Jul 19

Current report 8-K

Entered into a material agreement

Jul 11

Registration statement S-1/A

Registration statement

Jun 28

Registration statement S-1/A

Registration statement

Jun 22

Registration statement S-1/A

Registration statement

Jun 17

Registration statement S-1

Registration statement

Jun 9

Current report 8-K Events of Jun 8

Financial results, Regulation FD disclosure

Jun 2

Current report 8-K Events of May 26

Entered into a material agreement, Completed an acquisition or sale of assets, New debt or off-balance-sheet obligation, Unregistered sale of equity, Change to shareholders' rights, Change of auditor, Change in control, Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Code of ethics change or waiver, Change in shell company status

May 27

Current report 8-K Events of May 26

Delisting notice or listing transfer, Regulation FD disclosure

May 25

Current report 8-K Events of May 24

Shareholder vote results, Regulation FD disclosure

May 23

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Net income $1.17M

May 20

Proxy statement DEFA14A

Proxy statement

May 17

Proxy statement DEFA14A

Proxy statement

May 16

Late filing notice NT 10-Q

Late filing notice

May 11

Current report 8-K

Regulation FD disclosure

May 11

Proxy statement DEFA14A

Proxy statement

May 5

Proxy statement DEFM14A

Proxy statement

May 4

Current report 8-K/A Events of Mar 4

Other events

Apr 7

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Net income $11.11M

Apr 1

Late filing notice NT 10-K

Late filing notice

Mar 30

Current report 8-K Events of Mar 29

Regulation FD disclosure

Mar 30

Proxy statement DEFA14A

Proxy statement

Mar 4

Current report 8-K Events of Feb 28

Entered into a material agreement, New debt or off-balance-sheet obligation

Feb 11

Proxy statement PREM14A

Proxy statement

Jan 13

Proxy statement DEFA14A

Proxy statement

Dec 14

Current report 8-K/A Events of Dec 13

Current report

Dec 14

Current report 8-K Events of Dec 13

Regulation FD disclosure

Dec 14

Proxy statement DEFA14A

Proxy statement

Dec 14

Proxy statement DEFA14A

Proxy statement

Dec 13

Current report 8-K

Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure, Other events

Dec 13

Proxy statement DEFA14A

Proxy statement

Nov 29

Quarterly report 10-Q/A FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Net income $3M

Nov 24

Quarterly report 10-Q Ended Sep 30

Quarterly report for the period ended Sep 30, 2021

Nov 18

Current report 8-K Events of Nov 15

Earlier financial statements no longer reliable

Nov 15

Late filing notice NT 10-Q

Late filing notice

Aug 17

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Net income $13.24M

Aug 16

Late filing notice NT 10-Q

Late filing notice

May 20

Quarterly report 10-Q FY2021 Q1, ended Mar 31

Quarterly report for FY2021 Q1

Net loss $3.94M

May 17

Current report 8-K Events of May 14

Other events

May 17

Late filing notice NT 10-Q

Late filing notice

Apr 19

Current report 8-K

Other events

Mar 11

Current report 8-K Events of Mar 4

Other events

Mar 5

Current report 8-K Events of Mar 1

Entered into a material agreement, Unregistered sale of equity, Charter or bylaw amendment, or fiscal year change, Other events

Feb 22

Registration statement S-1/A

Registration statement

Feb 22

Registration statement S-1/A

Registration statement

Feb 12

Registration statement S-1

Registration statement